Synaptogenix Valuation
| SNPX Stock | USD 3.13 0.25 8.68% |
At this time, the company appears to be undervalued. Synaptogenix has a current Real Value of $5.71 per share. The regular price of the company is $3.13. Our model measures the value of Synaptogenix from inspecting the company fundamentals such as Shares Owned By Institutions of 0.29 %, return on equity of -0.075, and Shares Outstanding of 1.36 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Synaptogenix's valuation include:
Price Book 0.3314 | Enterprise Value -17.5 M | Enterprise Value Ebitda 1.2817 | Trailing PE 0.2921 |
Undervalued
Today
Please note that Synaptogenix's price fluctuation is relatively risky at this time. Calculation of the real value of Synaptogenix is based on 3 months time horizon. Increasing Synaptogenix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Synaptogenix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Synaptogenix Stock. However, Synaptogenix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.13 | Real 5.71 | Target 14.0 | Hype 3.14 | Naive 3.47 |
The intrinsic value of Synaptogenix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Synaptogenix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Synaptogenix helps investors to forecast how Synaptogenix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Synaptogenix more accurately as focusing exclusively on Synaptogenix's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Synaptogenix's intrinsic value based on its ongoing forecasts of Synaptogenix's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Synaptogenix's closest peers.
Synaptogenix Cash |
|
Synaptogenix Valuation Trend
Analysing the historical paterns of Synaptogenix's enterprise value and its market capitalization is a good way to estimate and gauge the value of Synaptogenix over time and is usually enough for investors to make rational market timing decisions.
Synaptogenix Total Value Analysis
Synaptogenix is at this time projected to have valuation of (17.51 M) with market capitalization of 4.07 M, debt of 5.53 M, and cash on hands of 28.75 M. The negative valuation of Synaptogenix may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Synaptogenix fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(17.51 M) | 4.07 M | 5.53 M | 28.75 M |
Synaptogenix Asset Utilization
One of the ways to look at asset utilization of Synaptogenix is to check how much profit was generated for every dollar of assets it reports. Synaptogenix has a negative utilization of assets of -0.14 %, losing $0.001382 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Synaptogenix shows how discouraging it operates for each dollar spent on its assets.Synaptogenix Ownership Allocation
About 97.77 % of Synaptogenix outstanding shares are held by general public with 1.94 (%) owned by insiders and only 0.29 % by institutional holders.Synaptogenix Profitability Analysis
Net Loss for the year was (6.04 M) with profit before overhead, payroll, taxes, and interest of 0.About Synaptogenix Valuation
Our relative valuation model uses a comparative analysis of Synaptogenix. We calculate exposure to Synaptogenix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Synaptogenix's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -6.3 K | -6.7 K |
Synaptogenix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 466.1 K |
Synaptogenix Current Valuation Indicators
Valuation refers to the process of determining the present value of Synaptogenix and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Synaptogenix we look at many different elements of the entity such as Synaptogenix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Synaptogenix, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Synaptogenix's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Synaptogenix's worth.Additional Tools for Synaptogenix Stock Analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.